ISRCTN26937594
Completed
未知
COmorbidity and Brief Interventions for Depression: The COBID Study
HS Leeds (UK)0 sites60 target enrollmentFebruary 27, 2012
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- HS Leeds (UK)
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Are currently engaging with a community drugs treatment, detox, maintenance or addiction recovery focused service in Leeds. Engagement is defined by:
- •1\.1\. Being currently registered with a formal addiction focused service or programme
- •1\.2\. Having had planned contact with the service within the last month
- •2\. Meet criteria for a current depressive disorder as defined by a score of 12 or more on the PHQ\-9 questionniare. Comorbid anxiety disorders are not exclusion criteria, as long as depression is the primary disorder
- •3\. Meet criteria for mild\-to\-moderate severity of drug dependence, as defined by a score between 0 ? 10 on the Severity of Dependence Questionnaire
- •4\. Have used alcohol, drugs, or methadone maintenance medication within the last month
Exclusion Criteria
- •1\. Are not currently engaging in a formal addiction treatment or support programme in Leeds
- •2\. Do not currently meet criteria as clinically significant for depressive disorder as defined by the PHQ\-9 questionnaire score
- •3\. Meet criteria for depression and a comorbid anxiety disorder, as identified by the GAD\-7 questionnaire. Where the anxiety disorder is more severe, has been of longer duration than depressive symptoms and is the patient's main concern.
- •4\. Meet criteria for a severe mental disorder including bipolar affective disorder, schizophrenia or other psychotic disorders. Patients with severe mental health problems who are already involved in psychiatric or secondary care mental health services.
- •5\. Are free of substances of dependence and/or maintained on disulfiram, acamprosate or naloxone.
- •6\. Those who have a severe drug or alcohol dependence, as defined by a score above 10 on the Severity of Dependence Questionnaire.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Computer-based psychological treatment for co-occurring depression and substance use problemsACTRN12607000437460niversity of Newcastle100
Not yet recruiting
Not Applicable
ightMood Intervention to reduce depression symptoms in obese adults: A randomized-controlled online intervention studyObese adults with depressive symptomsDRKS00029219VR-Universitätsklinik Essen128
Not yet recruiting
Not Applicable
Intervention for the Treatment of Depression in Virtual Reality (FlowVR)F32F32.1F32.2F32.8F32.9F33F33.1F33.2F33.8F33.9Depressive episodeModerate depressive episodeSevere depressive episode without psychotic symptomsOther depressive episodesDepressive episode, unspecifiedRecurrent depressive disorderRecurrent depressive disorder, current episode moderateRecurrent depressive disorder, current episode severe without psychotic symptomsOther recurrent depressive disordersRecurrent depressive disorder, unspecifiedDRKS00034078Asklepois Klinikum Harburg Zentrum für seelische Gesundheit Klinik für Psychiatrie, Psychotherapie und Psychosomatik66
Not yet recruiting
Not Applicable
The treatment of depressive disorders with online psychological treatment supported by a cliniciaDepressive disorders, depression, depressive symptoms, major depressive disorder, depressieve stoornissen, depressieve klachtenNL-OMON28356niversity Medical Center Groningen302
Terminated
Phase 2
Cannabidiol as an Adjunctive Treatment for Bipolar DepressionBipolar DisorderBipolar DepressionBipolar Affective DisorderNCT03310593Hospital de Clinicas de Porto Alegre36